Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View

Pfizer (PFE) reported second-quarter 2024 adjusted earnings per share of 60 cents, which comfortably beat the Zacks Consensus Estimate of 45 cents per share. Earnings declined 11% year over year due to lower revenues.Revenues came in at $13.28 billion, up 2% from the year-ago quarter on a reported basis, reflecting an operational increase of 3% and a negative currency impact of 1%. Total revenues beat the Zacks Consensus Estimate of$ 13.13 billion.Higher sales of Pfizer’s key non-COVID products like Vyndaqe ...